JPRN-UMIN000003982已完成未知
Randomized control trial of increased dose therapy with Entecavir vursus combination therapy with Entecavir and Adefovir in CHB patients with inadequate nucleoside analogue therapy - Compare the value of increased dose to combination therapy with nucleoside analogues
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 37years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Resistant to Entecavir 2. Intolerance to Entecavir 3. Pregnant, lactating women 4. Possibly pregnant women 5. Chronic kidney failure 6. Creatinine clearance of <=50 mL/ min 7. Severe heart diseases 8. Decompensated liver cirrhosis 9. Liver transplant patient 10. HIV/HBV superinfection
研究者
相似试验
已完成
不适用
A randomised controlled dose intensification clinical trial of chemotherapy with or without recombinant human granulocyte colony stimulating factor (G-CSF) in small cell lung cancer (SCLC)ung cancerSmall cell lung cancer (SCLC)CancerISRCTN15921116Medical Research Council (MRC) (UK)400
进行中(未招募)
不适用
Randomized continuation, dose escalation trial of Sorafenib in pts with advanced HCC with radiological progression on prior sorafenib treatment (Phase II study) - ONC-2006-004MedDRA version: 9.1Level: LLTClassification code 10019695Term: Hepatic neoplasmHepatocellular carcinomaEUCTR2007-000758-30-ITISTITUTO CLINICO HUMANITAS
已完成
2 期
A study on Siddha Herboââ?¬â??Mineral Medicine Naaga chendooramfor the Diabetes Neurological complication(Madhumega Avathaigal)CTRI/2021/07/035067ational Institute of Siddha80
招募中
3 期
A Randomized Controlled Trial on Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapypancreatic cancerpancreatic ductal adenocarcinoma10027656NL-OMON55290niversitair Medisch Centrum Utrecht120
尚未招募
不适用
Dose escalation study for inoperable esophageal cancer patients.inoperable oesophageal tumorsdefinitive chemoradiationdose escalationNL-OMON25587dept of Radiotherapy, AMC, AmsterdamArhems Radiotherapeutisch Institute, Arnhemdept of oncology, Erasmusmc, Rotterdam260
